A carregar...
Neurological effects of proprotein convertase subtilisin/kexin type 9 inhibitors: direct comparisons
AIMS: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors considerably alter the lipid profile. We sought to examine the rates of ischaemic stroke and neurocognitive deficits in patients treated with and without PCSK9 inhibitors. METHODS AND RESULTS: Randomized controlled trials (RCTs)...
Na minha lista:
| Publicado no: | Eur Heart J Qual Care Clin Outcomes |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5884103/ https://ncbi.nlm.nih.gov/pubmed/29121222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjqcco/qcx037 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|